Tvardi Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tvardi therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tvardi Therapeutics Today - Breaking & Trending Today

Opthea Appoints Sujal Shah to the Board of Directors

Former CymaBay Therapeutics CEO brings extensive leadership experience to his role as a Non-Executive Director and Audit and Risk Committee ChairMELBOURNE, Australia and PRINCETON, N.J., April 03, 2024 (GLOBE NEWSWIRE) Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced the appointment ....

Silvana Guerci Lena , Dan Spiegelman , Jeremy Levin , Sujal Shah , Fred Guerard , Daniel Spiegelman , Risk Committee Chairman , Exchange Commission , Investment In Biotechnology Companies , Lifesci Advisors , Gilead Sciences , Risk Committee , Opthea Limited , Credit Suisse , Roche Group , Northwestern University , Citigroup Inc , Company Board Of Directors The , Genentech United States Inc , Carnegie Mellon University Tepper School Of Business , Former Cymabay Therapeutics , Non Executive Director , Executive Director , Chief Executive Officer , Cymabay Therapeutics , Opthea Board ,